Please enable JavaScript to continue using this application.

Compare $AGEN vs $ENTA | Chartloom

Compare

$AGEN vs $ENTA

Agenus Inc · Enanta Pharmaceuticals Inc

AGEN

Agenus Inc

ENTA

Enanta Pharmaceuticals Inc

Compare $AGEN vs $ENTA

Comparing Agenus Inc and Enanta Pharmaceuticals Inc

AGENAgenus Inc

ENTAEnanta Pharmaceuticals Inc

AGENAgenus Inc

Market cap

$319M

P/E (TTM)

3.45x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.37x

Rev growth (TTM)

30.5%

YTD performance

137.5%

52W performance

83.9%

FCF yield

-30.8%

ENTAEnanta Pharmaceuticals Inc

Market cap

$364M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.51x

Rev growth (TTM)

0.7%

YTD performance

-13.3%

52W performance

10.6%

FCF yield

-10.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGEN

ENTA

Detailed metrics comparison

AGEN

Agenus Inc

ENTA

Enanta Pharmaceuticals Inc

Market Cap

AGEN$319M

ENTA$364M

Enterprise Value

AGEN$580M

ENTA$456M

Price

AGEN$7.67

ENTA$12.50

P/E Ratio

AGEN3.45x

ENTAN/A

P/S Ratio

AGEN2.41x

ENTA5.57x

EV/Sales

AGEN4.37x

ENTA6.99x

EV/EBITDA

AGEN13.66x

ENTA31.83x

P/B Ratio

AGEN110.53x

ENTA3.73x

P/FCF Ratio

AGENN/A

ENTAN/A

EV/FCF

AGEN-5.89x

ENTA-12.36x

PEG Ratio

AGENN/A

ENTAN/A

Forward P/E (NTM)

AGENN/A

ENTAN/A

Forward P/S (NTM)

AGEN3.37x

ENTA6.51x

Revenue (TTM)

AGEN$133M

ENTA$65M

Revenue Growth (YoY)

AGEN30.5%

ENTA0.7%

Forward Rev Growth

AGEN-1.2%

ENTA-7.3%

Gross Margin (TTM)

AGEN99.5%

ENTA0.0%

Operating Margin (TTM)

AGEN103.2%

ENTA0.0%

EBITDA Margin (TTM)

AGEN30.6%

ENTA-82.5%

Net Margin (TTM)

AGEN69.2%

ENTA-96.9%

FCF Margin (TTM)

AGEN-74.2%

ENTA-56.6%

Net Income (TTM)

AGEN$92M

ENTA$-63M

FCF (TTM)

AGEN$-99M

ENTA$-37M

EPS (TTM)

AGEN$2.22

ENTA-$2.17

ROE (TTM)

AGEN76.6%

ENTA-6184.0%

ROA (TTM)

AGEN44.9%

ENTA-2070.0%

ROIC (TTM)

AGEN48.7%

ENTA-2677.0%

Cash

AGEN$19M

ENTA$33M

Debt

AGEN$280M

ENTA$126M

Net Cash/Debt

AGEN$-261M

ENTA$-93M

Current Ratio (TTM)

AGEN0.34x

ENTA3.76x

Quick Ratio (TTM)

AGEN0.33x

ENTA3.62x

Debt/Equity (TTM)

AGEN4.01x

ENTA1.25x

Debt/Assets (TTM)

AGEN0.0%

ENTA0.0%

Interest Coverage (TTM)

AGENN/A

ENTAN/A

Net Debt/EBITDA (TTM)

AGEN0.00x

ENTA0.00x

Beta

AGEN1.50

ENTA0.72

52W Performance

AGEN83.9%

ENTA10.6%

YTD Performance

AGEN137.5%

ENTA-13.3%

% from 52W High

AGEN-25.6%

ENTA-27.1%

% from 52W Low

AGEN183.0%

ENTA22.5%

Asset Turnover (TTM)

AGEN0.65x

ENTA0.21x

FCF Yield (TTM)

AGEN-30.8%

ENTA-10.2%

Earnings Yield (TTM)

AGEN28.7%

ENTA-17.4%

Dividend Yield (TTM)

AGENN/A

ENTAN/A

Rule of 40

AGEN-43.8

ENTA-55.9

EV/GP/RG

AGENN/A

ENTAN/A

Ticker research

View AGEN research View ENTA research

Metric	AGEN Agenus Inc	ENTA Enanta Pharmaceuticals Inc
Market & Valuation
Market Cap	$319M	$364M
Enterprise Value	$580M	$456M
Price	$7.67	$12.50
P/E Ratio	3.45x	N/A
P/S Ratio	2.41x	5.57x
EV/Sales	4.37x	6.99x
EV/EBITDA	13.66x	31.83x
P/B Ratio	110.53x	3.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-12.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.37x	6.51x
Revenue & Growth
Revenue (TTM)	$133M	$65M
Revenue Growth (YoY)	30.5%	0.7%
Forward Rev Growth	-1.2%	-7.3%
Profitability
Gross Margin (TTM)	99.5%	0.0%
Operating Margin (TTM)	103.2%	0.0%
EBITDA Margin (TTM)	30.6%	-82.5%
Net Margin (TTM)	69.2%	-96.9%
FCF Margin (TTM)	-74.2%	-56.6%
Net Income (TTM)	$92M	$-63M
FCF (TTM)	$-99M	$-37M
EPS (TTM)	$2.22	-$2.17
ROE (TTM)	76.6%	-6184.0%
ROA (TTM)	44.9%	-2070.0%
ROIC (TTM)	48.7%	-2677.0%
Financial Health
Cash	$19M	$33M
Debt	$280M	$126M
Net Cash/Debt	$-261M	$-93M
Current Ratio (TTM)	0.34x	3.76x
Quick Ratio (TTM)	0.33x	3.62x
Debt/Equity (TTM)	4.01x	1.25x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.50	0.72
52W Performance	83.9%	10.6%
YTD Performance	137.5%	-13.3%
% from 52W High	-25.6%	-27.1%
% from 52W Low	183.0%	22.5%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.21x
FCF Yield (TTM)	-30.8%	-10.2%
Earnings Yield (TTM)	28.7%	-17.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-43.8	-55.9
EV/GP/RG	N/A	N/A
Ticker research	View AGEN research	View ENTA research

Valuation

P/E Ratio

AGEN

3.45x

P/S Ratio

AGEN

2.41x

ENTA

5.57x

EV/FCF

ENTA

-12.36x

AGEN

-5.89x

Growth & revenue

Revenue Growth TTM

AGEN

30.5%

ENTA

0.7%

Forward Revenue Growth

AGEN

-1.2%

ENTA

-7.3%

Profitability & performance

Gross Margin

AGEN

99.5%

ENTA

0.0%

ROE

AGEN

76.6%

ENTA

-6184.0%

FCF Yield %

ENTA

-10.2%

AGEN

-30.8%

52-Week Performance

AGEN

83.9%

ENTA

10.6%

Detailed metrics comparison

AGEN

Agenus Inc

ENTA

Enanta Pharmaceuticals Inc

Market Cap

AGEN$319M

ENTA$364M

Enterprise Value

AGEN$580M

ENTA$456M

Price

AGEN$7.67

ENTA$12.50

P/E Ratio

AGEN3.45x

ENTAN/A

P/S Ratio

AGEN2.41x

ENTA5.57x

EV/Sales

AGEN4.37x

ENTA6.99x

EV/EBITDA

AGEN13.66x

ENTA31.83x

P/B Ratio

AGEN110.53x

ENTA3.73x

P/FCF Ratio

AGENN/A

ENTAN/A

EV/FCF

AGEN-5.89x

ENTA-12.36x

PEG Ratio

AGENN/A

ENTAN/A

Forward P/E (NTM)

AGENN/A

ENTAN/A

Forward P/S (NTM)

AGEN3.37x

ENTA6.51x

Revenue (TTM)

AGEN$133M

ENTA$65M

Revenue Growth (YoY)

AGEN30.5%

ENTA0.7%

Forward Rev Growth

AGEN-1.2%

ENTA-7.3%

Gross Margin (TTM)

AGEN99.5%

ENTA0.0%

Operating Margin (TTM)

AGEN103.2%

ENTA0.0%

EBITDA Margin (TTM)

AGEN30.6%

ENTA-82.5%

Net Margin (TTM)

AGEN69.2%

ENTA-96.9%

FCF Margin (TTM)

AGEN-74.2%

ENTA-56.6%

Net Income (TTM)

AGEN$92M

ENTA$-63M

FCF (TTM)

AGEN$-99M

ENTA$-37M

EPS (TTM)

AGEN$2.22

ENTA-$2.17

ROE (TTM)

AGEN76.6%

ENTA-6184.0%

ROA (TTM)

AGEN44.9%

ENTA-2070.0%

ROIC (TTM)

AGEN48.7%

ENTA-2677.0%

Cash

AGEN$19M

ENTA$33M

Debt

AGEN$280M

ENTA$126M

Net Cash/Debt

AGEN$-261M

ENTA$-93M

Current Ratio (TTM)

AGEN0.34x

ENTA3.76x

Quick Ratio (TTM)

AGEN0.33x

ENTA3.62x

Debt/Equity (TTM)

AGEN4.01x

ENTA1.25x

Debt/Assets (TTM)

AGEN0.0%

ENTA0.0%

Interest Coverage (TTM)

AGENN/A

ENTAN/A

Net Debt/EBITDA (TTM)

AGEN0.00x

ENTA0.00x

Beta

AGEN1.50

ENTA0.72

52W Performance

AGEN83.9%

ENTA10.6%

YTD Performance

AGEN137.5%

ENTA-13.3%

% from 52W High

AGEN-25.6%

ENTA-27.1%

% from 52W Low

AGEN183.0%

ENTA22.5%

Asset Turnover (TTM)

AGEN0.65x

ENTA0.21x

FCF Yield (TTM)

AGEN-30.8%

ENTA-10.2%

Earnings Yield (TTM)

AGEN28.7%

ENTA-17.4%

Dividend Yield (TTM)

AGENN/A

ENTAN/A

Rule of 40

AGEN-43.8

ENTA-55.9

EV/GP/RG

AGENN/A

ENTAN/A

Ticker research

View AGEN research View ENTA research

Metric	AGEN Agenus Inc	ENTA Enanta Pharmaceuticals Inc
Market & Valuation
Market Cap	$319M	$364M
Enterprise Value	$580M	$456M
Price	$7.67	$12.50
P/E Ratio	3.45x	N/A
P/S Ratio	2.41x	5.57x
EV/Sales	4.37x	6.99x
EV/EBITDA	13.66x	31.83x
P/B Ratio	110.53x	3.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-12.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.37x	6.51x
Revenue & Growth
Revenue (TTM)	$133M	$65M
Revenue Growth (YoY)	30.5%	0.7%
Forward Rev Growth	-1.2%	-7.3%
Profitability
Gross Margin (TTM)	99.5%	0.0%
Operating Margin (TTM)	103.2%	0.0%
EBITDA Margin (TTM)	30.6%	-82.5%
Net Margin (TTM)	69.2%	-96.9%
FCF Margin (TTM)	-74.2%	-56.6%
Net Income (TTM)	$92M	$-63M
FCF (TTM)	$-99M	$-37M
EPS (TTM)	$2.22	-$2.17
ROE (TTM)	76.6%	-6184.0%
ROA (TTM)	44.9%	-2070.0%
ROIC (TTM)	48.7%	-2677.0%
Financial Health
Cash	$19M	$33M
Debt	$280M	$126M
Net Cash/Debt	$-261M	$-93M
Current Ratio (TTM)	0.34x	3.76x
Quick Ratio (TTM)	0.33x	3.62x
Debt/Equity (TTM)	4.01x	1.25x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.50	0.72
52W Performance	83.9%	10.6%
YTD Performance	137.5%	-13.3%
% from 52W High	-25.6%	-27.1%
% from 52W Low	183.0%	22.5%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.21x
FCF Yield (TTM)	-30.8%	-10.2%
Earnings Yield (TTM)	28.7%	-17.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-43.8	-55.9
EV/GP/RG	N/A	N/A
Ticker research	View AGEN research	View ENTA research